For example, in Thailand, introduction of generic medications was delayed for 1 year from the time compulsory licenses were approved. 32 The reason for this was that some patent-holding companies ...
About the author: Ellen ‘t Hoen is the director of Medicines Law & Policy , a group of legal and policy experts offering advice to international organizations and governments. She is the founder and ...
After sparring with GSK’s ViiV Healthcare over the price of its HIV medication dolutegravir, Colombia appears to be taking matters into its own hands. Colombian authorities on Tuesday said they plan ...
The use of so-called 'compulsory licenses' by developing countries to obtain cheaper drugs for HIV and AIDS by circumventing patents has not been the best strategy for achieving the lowest prices over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback